Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Farewell Meeting between Minister Agio Pereira and the Australian Special Representative for Greater Sunrise The Minister of the Presidency of the Council of Ministers and Timor-Leste's ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Home can be tricky! To help you make the right choice I'll run through the major differences between the two versions of Windows 11 and explain why they matter. You might assume Pro is better ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Buy SNDA near 20.28 target 26.36 stop loss @ 20.22 Details The technical summary data tells us to buy SNDA near 20.28 with an upside target of 26.36. This data also tells us to set a stop loss @ 20.22 ...